Pegvisomant improves Glucose Metabolism in Acromegaly: a meta-analysis of prospective interventional studies.
CONCLUSIONS: Independently of disease control, PEG in monotherapy or combined with SSAs seems to improve glucose metabolism, reducing FPG, HbA1c, FPI and HOMA-I.
PMID: 30869797 [PubMed - as supplied by publisher]
Source: The Journal of Clinical Endocrinology and Metabolism - Category: Endocrinology Authors: Feola T, Cozzolino A, Simonelli I, Sbardella E, Pozza C, Giannetta E, Gianfrilli D, Pasqualetti P, Lenzi A, Isidori AM Tags: J Clin Endocrinol Metab Source Type: research
More News: Academia | Acromegaly | Cholesterol | Databases & Libraries | Endocrinology | Insulin | Study